Alerts will be sent to your verified email
Verify Email
SHELTER
|
Shelter Pharma
|
Godavari Drugs
|
Kabra Drugs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
18.24 % | 14.06 % | 21.53 % |
|
5yr average Equity Multiplier
|
1.33 | 3.51 | -0.87 |
|
5yr Average Asset Turnover Ratio
|
1.65 | 1.24 | 0.0 |
|
5yr Avg Net Profit Margin
|
10.09 % | 3.28 % | 0.0 |
|
Price to Book
|
1.64 | 1.43 | 2.62 |
|
P/E
|
9.67 | 17.54 | 56.91 |
|
5yr Avg Cash Conversion Cycle
|
138.55 Days | 107.21 Days | 0.0 |
|
Inventory Days
|
71.81 Days | 47.15 Days | 0.0 |
|
Days Receivable
|
66.01 Days | 163.82 Days | 0.0 |
|
Days Payable
|
6.41 Days | 106.32 Days | 0.0 |
|
5yr Average Interest Coverage Ratio
|
84.13 | 2.61 | -1068.45 |
|
5yr Avg ROCE
|
25.47 % | 20.07 % | 21.53 % |
|
5yr Avg Operating Profit Margin
|
14.81 % | 8.03 % | 0.0 |
|
5 yr average Debt to Equity
|
0.03 | 1.34 | -1.45 |
|
5yr CAGR Net Profit
|
182.84 % | 1.18 % | 43.36 % |
|
5yr Average Return on Assets
|
13.79 % | 4.0 % | -21.34 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
52.32 % | 52.61 % | 0.0 |
|
Share Pledged by Promoters
|
0.0 | 0.22 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-4.57 % | -0.51 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Shelter Pharma
|
Godavari Drugs
|
Kabra Drugs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|